InChI=1S/C30H27N3O6/c1-4-11-38-15-9-10-19-17(12-15)23-24-18(14-31-27(24)34)22-16-7-5-6-8-20(16)33-26(22)25(23)32(19)21-13-30(36,28(35)37-3)29(33,2)39-21/h5-10,12,21,36H,4,11,13-14H2,1-3H3,(H,31,34)/t21-,29+,30+/m1/s1 |
ZZWAFVPZTZSAEM-RIGQTMPJSA-N |
CCCOc1ccc2n3[C@H]4C[C@](O)(C(=O)OC)[C@](C)(O4)n4c5ccccc5c5c6CNC(=O)c6c(c2c1)c3c45 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of myosin-light-chain kinase (EC 2.7.11.18).
|
|
View more via ChEBI Ontology
methyl (5S,6R,8R)-6-hydroxy-5-methyl-13-oxo-11-propoxy-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-6-carboxylate
|
9-hydroxy-9-methoxycarbonyl-8-methyl-14-n-propoxy-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo(a,g)cycloocta[cde]trinden-1-one
|
ChemIDplus
|
KT-5926
|
ChemIDplus
|
KT5926
|
ChemIDplus
|
126643-38-7
|
CAS Registry Number
|
ChemIDplus
|
24302813
|
Reaxys Registry Number
|
Reaxys
|
1659814
|
PubMed citation
|
Europe PMC
|
2325635
|
PubMed citation
|
Europe PMC
|
7954419
|
PubMed citation
|
Europe PMC
|
8182431
|
PubMed citation
|
Europe PMC
|
8529881
|
PubMed citation
|
Europe PMC
|
9240372
|
PubMed citation
|
Europe PMC
|
9635507
|
PubMed citation
|
Europe PMC
|
|